Biosplice Therapeutics
San Diego
About Biosplice Therapeutics
Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology. Samumed adopted a fresh operating philosophy from the beginning ’ one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $778.0M
- Last round: Grant (Mar 2024)
- Website: biosplice.com
- Phone: 8589529303
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/biosplice-therapeutics-97536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.